BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36503430)

  • 1. Intracellular osteopontin protects from autoimmunity-driven lymphoma development inhibiting TLR9-MYD88-STAT3 signaling.
    Rizzello C; Cancila V; Sangaletti S; Botti L; Ratti C; Milani M; Dugo M; Bertoni F; Tripodo C; Chiodoni C; Colombo MP
    Mol Cancer; 2022 Dec; 21(1):215. PubMed ID: 36503430
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nagasu A; Mukai T; Iseki M; Kawahara K; Tsuji S; Nagasu H; Ueki Y; Ishihara K; Kashihara N; Morita Y
    Cells; 2019 Apr; 8(5):. PubMed ID: 31052273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease.
    Cauwe B; Martens E; Sagaert X; Dillen C; Geurts N; Li S; Mertens J; Thijs G; Van den Steen PE; Heremans H; De Vos R; Blockmans D; Arnold B; Opdenakker G
    J Autoimmun; 2011 May; 36(3-4):239-52. PubMed ID: 21376533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP; Fan X; Ritthaler T; Sibalic V; Yu DJ; Loffing J; Kaissling B
    Autoimmunity; 1998; 28(3):139-50. PubMed ID: 9867126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
    Nickerson KM; Wang Y; Bastacky S; Shlomchik MJ
    PLoS One; 2017; 12(3):e0173471. PubMed ID: 28278279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA-like class R inhibitory oligonucleotides (INH-ODNs) preferentially block autoantigen-induced B-cell and dendritic cell activation in vitro and autoantibody production in lupus-prone MRL-Fas(lpr/lpr) mice in vivo.
    Lenert P; Yasuda K; Busconi L; Nelson P; Fleenor C; Ratnabalasuriar RS; Nagy PL; Ashman RF; Rifkin IR; Marshak-Rothstein A
    Arthritis Res Ther; 2009; 11(3):R79. PubMed ID: 19476613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exacerbated autoimmunity in the absence of TLR9 in MRL.Fas(lpr) mice depends on Ifnar1.
    Nickerson KM; Cullen JL; Kashgarian M; Shlomchik MJ
    J Immunol; 2013 Apr; 190(8):3889-94. PubMed ID: 23467932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenically active MYD88 mutations in human lymphoma.
    Ngo VN; Young RM; Schmitz R; Jhavar S; Xiao W; Lim KH; Kohlhammer H; Xu W; Yang Y; Zhao H; Shaffer AL; Romesser P; Wright G; Powell J; Rosenwald A; Muller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Staudt LM
    Nature; 2011 Feb; 470(7332):115-9. PubMed ID: 21179087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AID dysregulation in lupus-prone MRL/Fas(lpr/lpr) mice increases class switch DNA recombination and promotes interchromosomal c-Myc/IgH loci translocations: modulation by HoxC4.
    White CA; Seth Hawkins J; Pone EJ; Yu ES; Al-Qahtani A; Mai T; Zan H; Casali P
    Autoimmunity; 2011 Dec; 44(8):585-98. PubMed ID: 21585311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
    Ashman RF; Singh N; Lenert PS
    Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A signal adaptor SLAM-associated protein regulates spontaneous autoimmunity and Fas-dependent lymphoproliferation in MRL-Faslpr lupus mice.
    Komori H; Furukawa H; Mori S; Ito MR; Terada M; Zhang MC; Ishii N; Sakuma N; Nose M; Ono M
    J Immunol; 2006 Jan; 176(1):395-400. PubMed ID: 16365433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of allelic polymorphism of osteopontin in the development of lupus nephritis in MRL/lpr mice.
    Miyazaki T; Ono M; Qu WM; Zhang MC; Mori S; Nakatsuru S; Nakamura Y; Sawasaki T; Endo Y; Nose M
    Eur J Immunol; 2005 May; 35(5):1510-20. PubMed ID: 15832294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonizing miR-7 suppresses B cell hyperresponsiveness and inhibits lupus development.
    Wang M; Chen H; Qiu J; Yang HX; Zhang CY; Fei YY; Zhao LD; Zhou JX; Wang L; Wu QJ; Zhou YZ; Zhang W; Zhang FC; Zhang X; Lipsky PE
    J Autoimmun; 2020 May; 109():102440. PubMed ID: 32201226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined deficiency of proapoptotic regulators Bim and Fas results in the early onset of systemic autoimmunity.
    Hutcheson J; Scatizzi JC; Siddiqui AM; Haines GK; Wu T; Li QZ; Davis LS; Mohan C; Perlman H
    Immunity; 2008 Feb; 28(2):206-17. PubMed ID: 18275831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cathepsin K Deficiency Ameliorates Systemic Lupus Erythematosus-like Manifestations in
    Zhou Y; Chen H; Liu L; Yu X; Sukhova GK; Yang M; Kyttaris VC; Stillman IE; Gelb B; Libby P; Tsokos GC; Shi GP
    J Immunol; 2017 Mar; 198(5):1846-1854. PubMed ID: 28093526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cd72(c) is a modifier gene that regulates Fas(lpr)-induced autoimmune disease.
    Xu M; Hou R; Sato-Hayashizaki A; Man R; Zhu C; Wakabayashi C; Hirose S; Adachi T; Tsubata T
    J Immunol; 2013 Jun; 190(11):5436-45. PubMed ID: 23616572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9/MyD88 activation.
    He Y; Tian W; Zhang M; Qiu H; Li H; Shi X; Song S; Wen C; Chen J
    J Ethnopharmacol; 2023 Jun; 309():116283. PubMed ID: 36898449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.